Literature DB >> 204383

Involvement of calcium in cyclic nucleotide metabolism in human vascular smooth muscle.

H Hidaka, T Yamaki, M Asano, T Totsuka.   

Abstract

When cyclic nucleotide phosphodiesterase was purified from isolated smooth muscle layer of human aorta by DEAE-cellulose column chromatography, separated cyclic GMP phosphodiesterase activity was markedly stimulated in the presence of 10-20 micrometer of Ca2+ by a protein modulator which has similar physicochemical properties to troponin C. Synthetic compound, N-(6-aminohexl)-5-chloro-1-naphthalensulfonamide, which produced relaxations of arteries contracted by prostaglandin F2alpha or KCl was found to inhibit selectively this Ca2+-dependent cyclic GMP phosphodiesterase. This compound produced inhibition of superprecipitation of myosin B system obtained from mouse skeletal muscle and also inhibited adenosine triphosphatase activity of myosin B. Our data suggest that calcium is involved through a protein modulator in cyclic nucleotide metabolism of vascular smooth muscle and that the calcium-dependent protein modulator probably participates in the regulation of contractile response of vascular smooth muscle by affecting actomyosin ATPase activity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 204383     DOI: 10.1159/000158153

Source DB:  PubMed          Journal:  Blood Vessels        ISSN: 0303-6847


  9 in total

1.  Mechanism of leukotriene-induced contraction of isolated guinea pig tracheal smooth muscle.

Authors:  T Sasaki; K Takagi; T Satake; S Sugiyama; T Ozawa
Journal:  Lung       Date:  1984       Impact factor: 2.584

2.  The effect of calmodulin antagonists on amylase release from the rat parotid gland in vitro.

Authors:  T N Spearman; F R Butcher
Journal:  Pflugers Arch       Date:  1983-05       Impact factor: 3.657

3.  Role of [Ca2+]i in "Ca2+ stores depletion-Ca2+ entry coupling' in fibroblasts expressing the rat neurotensin receptor.

Authors:  P Gailly; E Hermans; J M Gillis
Journal:  J Physiol       Date:  1996-03-15       Impact factor: 5.182

4.  Role of calmodulin in platelet aggregation. Structure-activity relationship of calmodulin antagonists.

Authors:  M Nishikawa; H Hidaka
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

5.  N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation.

Authors:  H Hidaka; Y Sasaki; T Tanaka; T Endo; S Ohno; Y Fujii; T Nagata
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

6.  Quantitative radioautographic study of intracellular localization of calmodulin antagonist, W-7, in Chinese-hamster ovary cells.

Authors:  Y Fujii; S Ohno; H Hidaka
Journal:  Histochemistry       Date:  1985

7.  Calmodulin inhibitors improve erythropoiesis in Diamond-Blackfan anemia.

Authors:  Alison M Taylor; Elizabeth R Macari; Iris T Chan; Megan C Blair; Sergei Doulatov; Linda T Vo; David M Raiser; Kavitha Siva; Anindita Basak; Mehdi Pirouz; Arish N Shah; Katherine McGrath; Jessica M Humphries; Emma Stillman; Blanche P Alter; Eliezer Calo; Richard I Gregory; Vijay G Sankaran; Johan Flygare; Benjamin L Ebert; Yi Zhou; George Q Daley; Leonard I Zon
Journal:  Sci Transl Med       Date:  2020-10-21       Impact factor: 17.956

8.  Trifluoperazine inhibits phagocytosis in a macrophagelike cultured cell line.

Authors:  S B Horwitz; G H Chia; C Harracksingh; S Orlow; S Pifko-Hirst; J Schneck; L Sorbara; M Speaker; E W Wilk; O M Rosen
Journal:  J Cell Biol       Date:  1981-12       Impact factor: 10.539

9.  New antiarrhythmic targets to control intracellular calcium handling.

Authors:  H E Driessen; V J A Bourgonje; T A B van Veen; M A Vos
Journal:  Neth Heart J       Date:  2014-05       Impact factor: 2.380

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.